SecBot SecBot
8-K ·Filed Oct 29, 2026

DVA

DAVITA INC.
MIXED
Impact 5/10
Horizondays Processed3d 2h ago SEC0000927066-26-000132
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The GAAP miss is largely driven by a non-cash China impairment, while adjusted results and raised guidance low-end suggest underlying operational strength. Watch for further details on the China impairment and any impact on international segment trajectory.

DirectionMixed
Confidencehigh
Horizondays

Price Chart

Loading chart...

Executive Summary

DaVita reported Q3 2026 GAAP diluted EPS of $3.40 and adjusted diluted EPS of $3.82 on revenue of $3.578B. GAAP EPS missed the consensus estimate of $3.57, while revenue beat the $3.52B consensus. The company narrowed its 2026 adjusted operating income guidance range to $2,175M-$2,250M (from $2,150M-$2,250M) and raised the low end of adjusted EPS guidance to $14.30 (from $14.10), signaling modestly improved profitability expectations.

Key Financial Metrics

EPS (Adj.)
$3.82
est $3.57 · +7.0% · GAAP: $3.40
Revenue
$3.6B
est $3.5B · +1.6% · +4.6% YoY
Rating
beat
Free Cash Flow
$276.0M

Key Facts

  • Q3 2026 consolidated revenues of $3.578B, up 4.6% from $3.420B in Q3 2025.
  • GAAP diluted EPS of $3.40 vs consensus $3.57 (miss).
  • Adjusted diluted EPS of $3.82 vs consensus $3.57 (beat).
  • Adjusted operating income of $561M (15.7% margin) vs $499M GAAP operating income (14.0% margin).
  • Non-cash goodwill impairment charge of $62M related to China business reduced GAAP results.
  • 2026 guidance: adjusted operating income raised to $2,175M-$2,250M; adjusted EPS low end raised to $14.30.
  • Free cash flow of $276M in Q3, $980M trailing twelve months.
  • Repurchased 0.6M shares for $111M in Q3; additional 0.5M shares for $87M through Oct 27.
  • U.S. dialysis normalized non-acquired treatment growth of 0.4% year-over-year.
  • Integrated kidney care risk-based patients grew to 80,800 from 64,900 in Q2 2026.

Financial Impact

GAAP EPS $3.40 missed consensus by $0.17 (4.8%); adjusted EPS $3.82 beat by $0.25 (7.0%). Revenue $3.578B beat consensus by $58M (1.6%).

revenueepsoperating incomefree cash flow

Segment Breakdown

SegmentRevenue
U.S. dialysis$3.0B
Integrated kidney care$144.0M
Other U.S. ancillary$10.0M
International$398.0M

Risk Factors

  • GAAP EPS miss of 4.8% vs consensus may pressure the stock near term.
  • China goodwill impairment of $62M signals ongoing challenges in international operations.
  • Patient care costs per treatment rose to $280.22 from $277.40 sequentially, pressuring margins.
  • Leverage ratio increased slightly to 3.38x from 3.37x; weighted average interest rate rose to 5.54%.
  • Free cash flow trailing twelve months declined to $980M from $1,308M in the prior period.

Market Snapshot

Exchange
NYSE
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
54% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000927066-26-000132
Document: dva-20261029.htm0000927066-26-000132
Document: 0000927066-26-000132-index-headers.html0000927066-26-000132
Document: 0000927066-26-000132-index.html0000927066-26-000132
Document: 0000927066-26-000132.txt0000927066-26-000132
8-K Data (Synthetic)0000927066-26-000132
9 reports for DVA
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +24.56%May 5, 2026
Filters
Rows
Reports for DVA, sortable and filterable
TypeNow
Oct 29, 2026
3d ago
8-K
MIXED ★ 5/10
No priceawaiting T+60awaiting T+60No price
Oct 29, 2026
3d ago
Press Release
BULLISH ★ 6/10
$184.00awaiting T+60awaiting T+60$187.50 (+1.90%)
Oct 23, 2026
9d ago
Institutional Cluster
NEUTRAL ★ 2/10
$183.64awaiting T+60awaiting T+60$187.50 (+2.10%)
Aug 4, 2026
12w ago
8-K
BULLISH ★ 6/10
$187.61 $193.31▲ +3.04%▲ +3.10%$187.50 (−0.06%)
Jun 15, 2026
19w ago
Court Ruling
NEUTRAL ★ 1/10
$208.98 $181.55▼ −13.13%▼ −14.99%$187.50 (−10.28%)
Jun 8, 2026
20w ago
8-K
MIXED ★ 5/10
$198.19 $178.83▼ −9.77%▼ −13.58%$187.50 (−5.39%)
May 18, 2026
23w ago
Insider Cluster
NEUTRAL ★ 3/10
$194.38 $179.17▼ −7.82%▼ −13.84%$187.50 (−3.54%)
May 13, 2026
24w ago
Insider Cluster
BEARISH ★ 6/10
$192.30 $183.48▲ +4.59%▲ +7.91%$187.50 (+2.49%)
May 5, 2026
25w ago
8-K
BULLISH ★ 8/10
$191.76 $238.86▲ +24.56%▲ +23.49%$187.50 (−2.22%)
Showing 9 of 9

US Market Status

Market Closed · Opens Mon (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 29, 2026